Activation of murine resident peritoneal macrophages by a cell wall extract of Candida albicans

References

• Bistoni F, Vecchiarelli A, Cenci E, Puccetti P, Marconi P, Cassone A. Evidence for macrophage-mediated protection against lethal Candida albicans infection. Infect Immun 1986; 51: 668–674
   PubMed Web of Science ®Google Scholar
• Mazzolla R, Barluzzi R, Romani L, Mosci P, Bistoni F. Anti-Candida resistance in the mouse brain and effect of intracerebral administration of interleukin-1. J. Gen Microbiol 1991; 137: 1799–1804
   PubMedGoogle Scholar
• Vecchiarelli A, Puliti M, Torosantucci A, Cassone A, Bistoni F. In vitro production of tumor necrosis factor by murine splenic macrophages stimulated with mannoprotein constituents of Candida albicans cell wall. Cell Immunol 1991; 134: 65–76
   PubMed Web of Science ®Google Scholar
• Garner RE, Rubanowice K, Sawyer RT, Hudson JA. Secretion of TNF-a by alveolar macrophages in response to Candida albicans mannan. J Leukocyte Biol 1994; 55: 161–168
   PubMed Web of Science ®Google Scholar
• Raponi G, Ghezzi MC, Mancini C, Filadoro F. Preincubation of Candida albicans strains with amphotericin B reduces tumor necrosis factor alpha and interleukin-6 release by human monocytes. Antimicrob Agents Chemother 1993; 37: 1958–1961
   PubMed Web of Science ®Google Scholar
• Raponi G, Ghezzi MC, Mancini C, Filadoro F. Culture filtrates and whole heat-killed Candida albicans stimulate human monocytes to release Interleukin-6. Microbiologica 1993; 16: 267–274
   PubMed Web of Science ®Google Scholar
• Djeu JY, Blanchard DK, Richards AL, Friedman H. Tumor necrosis factor induction by Candida albicans from human natural killer cells and monocytes. J Immunol 1988; 141: 4047–4052
   PubMed Web of Science ®Google Scholar
• Blasi E, Pitzurra L, Puliti M, Bartoli A, Bistoni F. Candida albicans hyphal form enhances tumor necrosis factor mRNA levels and protein secretion in murine ANA-1 macrophages. Cell Immunol 1992; 142: 137–144
   PubMed Web of Science ®Google Scholar
• Scaringi L, Marconi P, Boccanera M, Tissi L, Bistoni F, Cassone A. Cell wall components of Candida albicans as immunomodulators: induction of natural killer and macrophagemediated peritoneal cell cytotoxicity in mice by mannoprotein and glucan fractions. J Gen Microbiol 1988; 134: 1265–1274
   PubMedGoogle Scholar
• Cuff, C, Packer, B, Rivas, V, et al. Induction of immunosuppressive B-lymphocytes with components of Candida albicans. Host Defenses and Immunomodulation to Intracellular Pathogens, TK Eisenstein, Bullock, WE, Flanna, N. Plenum Press, New York 1988; 367–378, In
   Google Scholar
• Cuff CF, Packer BJ, Rogers TJ. A further characterization of Candida albicans-induced suppressor B-cell activity. Immunology 1989; 68: 80–86
   PubMed Web of Science ®Google Scholar
• Cuff CF, Rogers CM, Lamb BJ, Rogers TJ. Induction of suppressor cells in vitro by Candida albicans. Cell Immunol 1989; 100: 47–56
   Web of Science ®Google Scholar
• Cuff CF, Taub DD, Rogers TJ. The induction of T-suppressor cells with a soluble extract of Candida albicans. Cell Immunol 1989; 122: 71–82
   PubMed Web of Science ®Google Scholar
• Rivas V, Rogers TJ. Studies on the cellular nature of Candida albicans-induced suppression. J Immunol 1993; 130: 376–379
   Google Scholar
• Carrow EW, Domer JE. Immunoregulation in experimental murine candidiasis: specific suppression induced by Candida albicans cell wall glycoprotein. Infect Immun 1985; 49: 172–181
   PubMed Web of Science ®Google Scholar
• Piccolella E, Lombardi G, Morelli R. Generation of suppressor cells in the response of human lymphocytes to a polysaccharide from Candida albicans. J Immunol 1981; 126: 2151–2155
   PubMed Web of Science ®Google Scholar
• Domer JE, Moser SA. Experimental murine candidiasis: cellmediated immunity after cutaneous challenge. Infect Immun 1978; 20: 88–98
   PubMed Web of Science ®Google Scholar
• Dubois M, Gilles KA, Hamilton JK, Rebers PA, Smith F. Colorimetric method for determination of sugars and related substances. Anal Chem 1956; 28: 350–356
   Web of Science ®Google Scholar
• Kessler G, Nickerson WJ. Glucomannan-protein complexes from cell walls of yeasts. J Biol Chem 1995; 234: 2281–2285
   Google Scholar
• Korn ED, Northcote DH. Physical and chemical properties of polysaccharides and glycoprotein of the yeast-cell wall. Biochem J 1960; 75: 12–17
   PubMed Web of Science ®Google Scholar
• Domer JE, Hamilton JG, Harkin JC. Comparative study of the cell walls of the yeastlike and mycelial phases of Histoplasma capsulatum. J Bacteriol 1967; 94: 466–474
   PubMed Web of Science ®Google Scholar
• Johnston RB. Secretion of superoxide anion. Methods for Studying Mononuclear Phagocytes, DO Adams, PJ Edelson, HS Koren. Academic Press, New York 1981; 489–497, In
   Google Scholar
• Aarden LA, De Groot RA, Schaap OL, Lansdorp PM. Production of hybridoma growth factor by human monocytes. Eur J Immunol 1987; 17: 1411–1416
   PubMed Web of Science ®Google Scholar
• Orencole SF, Dinarello CA. Characterization of a subclone (D10s) of the D10.G4.1 helper T-cell line which proliferates to attomolar concentrations of interleukin-1 in the absence of mitogens. Cytokine 1989; 1: 14–22
   PubMedGoogle Scholar
• Green LM, Reade JL, Ware CF. Rapid colorimetric assay for cell viability: application to the quantitation of cytotoxic and growth inhibitory lymphokines. J Immunol Meth 1984; 70: 257–268
   PubMed Web of Science ®Google Scholar
• Ausiello CM, Urbani F, Gessani S, Spagnoli GC, Gomez MJ, Cassone A. Cytokine gene expression in human peripheral blood mononuclear cells stimulated by mannoprotein constituents from Candida albicans. Infect Immun 1993; 61: 4105–4111
   PubMed Web of Science ®Google Scholar
• Hoffman OA, Olson EJ, Limper AH. Fungal β-glucans modulate macrophage release of tumor necrosis factor-a in response to bacterial lipopolysaccharide. Immun Lett 1993; 37: 19–25
   PubMed Web of Science ®Google Scholar
• Jeremias J, Kalo-Klein A, Witkin SS. Individual differences in tumour necrosis factor and interleukin-1 production induced by viable and heat-killed Candida albicans. J Med Vet Mycol 1991; 29: 157–163
   PubMedGoogle Scholar
• Lombardi G, Piccolella E, Vismara D, Colizzi V, Asherson GL. Candida albicans polysaccharide extract (MPPS) and PPD stimulate the production of interleukin-1 and lymphocyte proliferation. Clin Exp Immunol 1984; 58: 581–586
   PubMed Web of Science ®Google Scholar
• Pabst MJ, Johnston RB. Increased production of superoxide anion by macrophages exposed in vitro to muramyl dipeptide or lipopolysaccharide. J Exp Med 1980; 151: 101–114
   PubMed Web of Science ®Google Scholar
• Fleischmann J, Church JA, Lehrer RI. Primary Candida meningitis and chronic granulomatous disease. Am J Med Sci 1986; 291: 334–341
   PubMed Web of Science ®Google Scholar
• Scales WE, Chensue SW, Kunkel SL. Interleukin-6 expression in immunologically elicited murine macrophages. Pathobiology 1992; 60: 289–296
   PubMed Web of Science ®Google Scholar
• Van Snick J. Interleukin-6: an overview. Annu Rev. Immunol 1990; 8: 253–278
   PubMed Web of Science ®Google Scholar
• Steinshamn S, Waage A. Tumor necrosis factor and interleukin-6 in Candida albicans infection in normal and granulocytopenic mice. Infect Immun 1992; 60: 4003–4008
   PubMed Web of Science ®Google Scholar
• Torosantucci A, Bromuro C, Gomez MJ, Ausiello CM, Urbani F, Cassone A. Identification of a 65-kDa mannoprotein as a main target of human cell-mediated immune response to Candida albicans. J Infect Dis 1993; 168: 427–435
   PubMed Web of Science ®Google Scholar
• Riipi L, Carlson E. Tumor necrosis factor (TNF) is induced in mice by Candida albicans: role of TNF in fibrinogen increase. Infect Immun 1990; 58: 2750–2754
   PubMed Web of Science ®Google Scholar
• Blasi E, Puliti M, Pitzurra L, Bartoli A, Bistoni F. Heterogeneous secretory response of phagocytes from different anatomical districts to the dimophic fungus Candida albicans. Cell Immunol 1994; 153: 239–247
   PubMed Web of Science ®Google Scholar
• Blasi E, Farinelli S, Varesio L, Bistoni F. Augmentation of GG2EE macrophage cell line-mediated anti-Candida activity by gamma interferon, tumor necrosis factor, and interleukin 1. Infect Immun 1990; 58: 1073–1077
   PubMed Web of Science ®Google Scholar
• Djeu JY, Blanchard DK, Halkias D, Friedman H. Growth inhibition of Candida albicans by human polymorphonuclear neutrophils: activation by interferon-γ and tumor necrosis factor. J Immunol 1986; 137: 2980–2984
   PubMed Web of Science ®Google Scholar
• Ferrante A. Tumor necrosis factor alpha potentiates neutrophil antimicrobial activity: increased fungicidal activity against Torulopsis glabrata and Candida albicans and associated increases in oxygen radical production and lysosomal enzyme release. Infect Immun 1989; 57: 2115–2122
   PubMed Web of Science ®Google Scholar
• Louie, A, Baltch, AL, Smith, RP, et al. Tumor necrosis factor alpha has a protective role in a murine model of systemic candidiasis. Infect Immun 1994; 62: 2761–2772
   PubMed Web of Science ®Google Scholar
• Minami A, Fujimoto K, Ozaki Y, Nakamura S. Augmentation of host resistance to microbial infections by recombinant human interleukin-1a. Infect Immun 1988; 56: 3116–3120
   PubMed Web of Science ®Google Scholar
• Palma C, Cassone A, Serbousek D, Pearson CA, Djeu JY. Lactoferrin release and interleukin-1, interleukin-6, and tumor necrosis factor production by human polymorphonuclear cells stimulated by various lipopolysaccharides: relationship to growth inhibition of Candida albicans. Infect Immun 1992; 60: 4604–4611
   PubMed Web of Science ®Google Scholar
• Van't Wout JW, Van der Meer JWM, Barza M, Dinarello CA. Protection of neutropenic mice from lethal Candida albicans infection by recombinant interleukin 1. Eur J Immunol 1988; 18: 1143–1146
   PubMed Web of Science ®Google Scholar
• Djeu JY, Serbousek D, Blanchard DK. Release of tumor necrosis factor by human polymorphonuclear leukocytes. Blood 1990; 76: 1405–1409
   PubMed Web of Science ®Google Scholar
• Dubravec DB, Spriggs DR, Mannick JA, Rodrick ML. Circulating human peripheral blood granulocytes synthesize and secrete tumor necrosis factor a. Proc Nat Acad Sci USA 1990; 87: 6758–6761
   PubMed Web of Science ®Google Scholar
• Tiku K, Tiku ML, Skosey JL. Interleukin 1 production by human polymorphonuclear neutrophils. J Immunol 1986; 136: 3677–3684
   PubMed Web of Science ®Google Scholar
• Brandwein SR. Regulation of interleukin 1 production by mouse peritoneal macrophages. Effects of arachidonic acid metabolites, cyclic nucleotides, and interferons. J Biol Chem 1986; 261: 8624–8632
   PubMed Web of Science ®Google Scholar
• Kunkel SL, Wiggins RC, Chensue SW, Larrick J. Regulation of macrophage tumor necrosis factor production by prostaglandin E2. Biochem Biophys Res Commun 1986; 137: 404–410
   PubMed Web of Science ®Google Scholar
• Hamilton TA. Molecular mechanisms in the activation of mononuclear phagocytes. Immunopharmacology, SC Gilman, TJ Rogers. Tellford Press, Caldwell, NJ 1989; 213–252, In
   Google Scholar